Medifast's strong quarterly performance, investments in growth strategies, and undervalued stock make it an attractive ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Medifast (MED) delivered earnings and revenue surprises of 333.33% and 3.48%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

DA Davidson has a “Neutral” rating and a $17.00 price objective on the stock. The consensus estimate for Medifast’s current full-year earnings is $1.24 per share. DA Davidson also issued est ...

Of these, perhaps no stock market trend is more popular than ... One company value investors might notice is MEDIFAST (MED). MED is currently holding a Zacks Rank of #1 (Strong Buy) and a Value ...

Q3 2024 Earnings Call Transcript November 4, 2024 Medifast, Inc. beats earnings expectations. Reported EPS is $0.1029, ...

Medifast is focusing on innovative health solutions and customer acquisition strategies to drive future growth. For a thorough assessment of MED stock, go to TipRanks’ Stock Analysis page. Medifast ...

For the current quarter ending in December, Medifast expects its per-share earnings to range from 10 cents to 65 cents. The company said it expects revenue in the range of $100 million to $120 ...